help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roy, S. K.
Right arrow Articles by Albee, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, S. K.
Right arrow Articles by Albee, L.
Endocrinology Vol. 141, No. 12 4449-4456
Copyright © 2000 by The Endocrine Society


ARTICLES

Requirement for Follicle-Stimulating Hormone Action in the Formation of Primordial Follicles during Perinatal Ovarian Development in the Hamster1

Shyamal K. Roy and Laura Albee

Leland J. and Dorothy L. Olson Center for Women’s Health, Departments of Obstetrics and Gynecology (S.K.R., L.A.), and Physiology and Biophysics (S.K.R.), University of Nebraska Medical Center, Omaha, Nebraska 68198-4515

Address all correspondence and requests for reprints to: Shyamal K. Roy, BH 3040, Departments of Ob/Gyn and Physiology and Biophysics, University of Nebraska Medical Center, 984515 Nebraska Medical Center, Omaha, Nebraska 68198-4515. E-mail: skroy{at}unmc.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Whereas FSH action is critical for the growth of preantral follicles, its role in the development of primordial follicles is controversial. The objective of the present study was to evaluate whether perinatal (fetal through early postnatal) FSH action is needed for the formation of primordial follicles, which first appear in the hamster ovary on the 7th to 8th day of postnatal life. A single dose of FSH-specific polyclonal antibody was injected into pregnant hamsters on the 12th, 13th, or 14th day of gestation and into newborn hamsters. Some of the antibody-exposed postnatal hamsters were injected with a single dose of equine CG (eCG) to check the reversibility of the antibody action. Ovaries were collected on D8pn or D12pn, and the percentage of primordial, primary, and secondary follicles was quantitated morphometrically. Ovaries of 8-day-old hamsters that were born to mothers treated with a single sc dose of the anti-FSH-antibody on day 12 of gestation had significantly reduced numbers of primordial follicles, compared with those treated with preimmune serum or saline (2.4% vs. 25%); however, the antibody inhibition was nearly completely reversed (~18%) by a single injection of eCG on the first day of life. Delaying antibody treatment during late gestation caused a time-dependent block in granulosa cell differentiation, with a consequent proportional increase in the percentage of primordial follicles. This indicates that FSH-induction of primordial follicle development begins at a critical time of ovarian development. On the other hand, shortening the postnatal duration of eCG exposure reduced the degree of reversal, suggesting that prolonged perinatal FSH action is essential for developing the full gamut of primordial follicles. These results provide the first direct evidence that FSH action during fetal ovarian development is critical for the onset of primordial follicle formation.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE ONSET OF differentiation of ovarian somatic cells into granulosa cells, forming the first cohort of primordial follicles, heralds the beginning of folliculogenesis in the mammalian ovary. Follicular development in the ovary depends critically on the action of FSH, the primary gonadotropin for folliculogenesis (1). FSH action in the ovary is restricted to granulosa cells, regardless of the state of ovarian development (2, 3). FSH functions by interacting with its cognate G protein-coupled glycoprotein receptor, which resides in the cell membrane (3). Factors regulating the formation of primordial follicles remain an enigma, because it requires the active participation of the oocyte and somatic cells, each of which has its share of autocrine/paracrine factors (4). Whereas TGF-ß2 isoform has been detected in differentiating somatic cells in the perinatal hamster ovary during primordial and primary follicle formation (5), neuropeptide Y and cAMP have been suggested to play a major role in FSH receptor induction in the neonatal rat ovary (6). Despite the presence of an appreciable amount of FSH in the serum of perinatal rats (7), mice (8), and hamsters (5, 9), it is unclear whether, during perinatal ovarian morphogenesis, FSH plays any role in the onset of primordial follicle development. Recent studies have shown that an inactivating mutation of either FSH-ß-subunit gene (10) or FSH-receptor gene (11) results in cessation of follicular development beyond preantral stages in the homozygous mouse. However, a naturally occurring inactivating mutation in human FSH receptors results in significant reduction in FSH signaling, coinciding with hypoplastic ovaries containing few follicles (12, 13, 14). Although, primordial follicles have been located in the ovaries of women with FSH-receptor mutation (12, 13, 14), whether their number is comparable with fertile women remains unclear. Aittomaki et al. (13) have suggested that ovaries with FSH-receptor mutation may not be totally resistant to large amounts of FSH, which may induce some follicular development, particularly at the earlier stages, but normal folliculogenesis never occurs. At present, data based on genetic manipulation is virtually limited to the mouse. FSH stimulates in vitro growth of hamster primary and secondary follicles (15, 16, 17, 18). The objective of the present study was to determine whether perinatal FSH plays any role in the differentiation of somatic cells into early granulosa cells at the onset of hamster primordial follicle development. In contrast to rats or mice, ovaries of newborn hamsters contain oocytes in the 1st meiotic prophase and scattered undifferentiated somatic cells; morphologically distinct primordial follicles are not present until 7–8 days postnatal (D7pn–D8pn) (5, 9, 19). Therefore, the perinatal hamster ovary is an ideal model to address the inducible role of FSH in primordial folliculogenesis.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Adult golden hamsters with three consecutive estrous cycles were housed under a 14-h light, 10-h dark cycle, in climate-controlled quarters, according to United States Department of Agriculture and Institutional Animal Care and Use Committee guidelines. Moreover, the use of hamsters in this study was approved by the Institutional Animal Care and Use Committee.

Generation and determination of specificity and efficacy of polyclonal anti-FSH antibody
An anti-FSH antibody was raised in New Zealand white rabbits using ovine FSH-20 with 5% and 2% LH and TSH contamination, respectively (20). Blood was collected, before antigen injection, for preimmune serum preparation. After a satisfactory titer was reached, the specificity of the antiserum was verified, first by an enzyme-linked immunosorbent assay using ovine-FSH-20 and ovine-LH-25, and then by Western immunoblotting and chemiluminescence (21) using 1 µg each of ovine-FSH-20, ovine-LH-25, ovine PRL-19, and equine CG (eCG).

To verify the ability of the antibody to neutralize FSH action in vivo, cyclic hamsters were injected sc with 200 µl of the anti-FSH-antiserum, on proestrus, at 1600 h, after the periovulatory LH surge but before the second FSH surge at 2200 h (20); the latter induces preantral follicle growth (15) and recruitment for ovulation (for review, see Ref. 1). Animals were checked the next morning for the estrous vaginal discharge and again on estrus of the next cycle; ovaries were collected and processed for morphological evaluation of follicle development. Because pure hamster FSH does not exist, the cross-reactivity of the FSH antiserum with hamster FSH was assessed by 1) competition assay; and 2) Western immunoblotting of hamster pituitary lysate. For the former protocol, [125I]-ovine FSH was incubated at 4 C with an optimal dilution of the antiserum in the presence of 0.1, 0.5, 1, 10, 100, and 1000 ng ovine-FSH or LH, 10, 20, 40, 80, and 100 µl of serum from proestrous (day 4: 0900 h) or long-term (10 days) hypophysectomized hamsters for 20 h. The antibody-[125I]-FSH complex was precipitated with goat-antirabbit-IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) and counted in a Packard (Packard Instrument Co., Meriden, CT) auto- gamma counter. The results were expressed as percentage binding against the amounts of FSH or volume of serum. For Western immunoblotting of hamster pituitary FSH, fresh pituitary glands were obtained from proestrous (D4: 0900 h) hamsters and were homogenized in ice-cold 1x RIPA buffer [PBS (pH 7.4), 0.1% SDS, 1% NP-40, and 0.5% deoxycholate] containing a protease inhibitor cocktail (Sigma, St. Louis, MO). After 30 min on ice, the mixture was centrifuged for 20 min at 12,000 rpm in a refrigerated IEC microfuge, the protein content of the supernatant was determined by the BCA protein assay kit (Pierce Chemical Co., Rockford, IL), and 40 µg of hamster pituitary protein was electrophoresed under a reducing condition, transferred to a nitrocellulose membrane, and probed with the FSH-antiserum, as described previously (21). Positive controls were 0.25 and 0.5 µg of ovine-FSH-20.

Determination of the optimal window of FSH action during primordial folliculogenesis
Hamsters were mated on proestrous evening, and the presence of sperm in the vagina next morning was considered as day 1 of gestation (1DG). Pregnant hamsters were injected sc with 200 µl anti-FSH-serum either on 12DG, 13DG, or 14DG; or pups were injected sc with 20 µl of the antiserum on D1pn. Some animals received preimmune serum or saline as controls. On D8pn, pups were anesthetized with nembutal, blood was collected for FSH RIA, and ovaries were saved for morphometric quantitation of primordial and primary follicle development.

Based on the results, in the next experiment, the antiserum was injected into pregnant hamsters on 10DG. Because ovarian structures consisting of germ cells and somatic cells are present by day 12 of fetal life, the objective was to deprive somatic cells of any FSH action during ovary formation so that primordial follicle formation could be stopped completely. Ovaries were collected on D8pn, and follicle development was quantitated morphometrically.

Determination of the presence of functional FSH receptor in fetal hamster ovaries
Because [125I]-FSH autoradiography is inconclusive for fetal ovaries and RRA is often not feasible because of limited ovarian materials, production of cAMP, in response to FSH in vitro, was assessed, following (with modification) a protocol described by Sokka and Huhtaniemi (22). Ovaries were collected from 13-day-old fetal hamsters and were cultured in 0.5 ml DMEM, as described previously (23), in the presence of 0.5 mM methylisobutylxanthine (MIX, Calbiochem, San Diego, CA) and in the presence or absence of 50 ng/ml ovine-FSH-19 (NIH) or 50 µM forskolin (Calbiochem, San Diego, CA) for 24 h. After termination, the medium was placed in a boiling water bath for 5 min, clarified by centrifugation, and stored at -80 C for cAMP RIA.

eCG reversal of the antibody inhibition of primordial follicle development
To determine whether the effect of the antiserum was attributable to the inactivation of endogenous FSH or antibody-mediated toxicity, pregnant hamsters received 200 µl antiserum on 12DG, and pups received an sc injection of 20 IU eCG (Sigma) or saline on D1pn; ovaries were collected on D8pn for follicular morphometry. The rationale for using eCG was 1) its longer half-life; 2) no cross-reactivity with the anti-FSH-antiserum; and 3) binding to the FSH receptor and induction of FSH-like activity in the hamster (24).

To determine the time-course of eCG rescue of primordial follicle formation, pregnant females were injected with 200 µl of the anti-FSH-antiserum on 12DG, and pups received 20 IU eCG either on D1, D4, or D6pn, with ovaries retrieved on D8pn.

Reversibility of the antiserum inhibition by endogenous FSH
Whether inactivation of FSH during pregnancy delays primordial follicle development or makes the ovary refractory to subsequent FSH signaling was determined by injecting pregnant hamsters with 200 µl of the antiserum sc on 12DG or 13DG and ovaries collected on D12pn, at a time when ovaries of untreated hamsters contain primordial through secondary follicles with 4 layers of granulosa cells (5).

Morphometric quantitation of primordial, primary, and secondary follicle development
The percentage of follicles in different stages of development was assessed from 2-µm-thick hematoxylin and eosin-stained plastic sections, under 650x magnification, using the Image Pro Plus image analysis software (Media Cybernetics, Silver Spring, MD). Because primordial oocytes (i.e. oocytes in clusters and without any somatic cell partners) dominate the ovaries of 8-day-old hamsters (5, 19), the total number of oocytes with nucleolus, regardless of their follicular association, was counted in a given optical field. Next, the number of follicles, at various stages, corresponding to those oocytes was determined. The fields were chosen at random from the entire ovary, and 250 or more oocytes for each ovary were counted. The proportion of follicles in an ovary was then expressed as percentage of oocytes. An oocyte surrounded by the cytoplasmic processes of at least one flattened parenchymal cell was considered a primordial follicle, whereas a primary follicle was defined as one surrounded by a complete layer of parenchymal cells, of which the majority were cuboidal. Primordial follicles were identified by a double-blind screening of coded slides, and the code was revealed after completion of follicle counting.

Determination of serum levels of FSH and rabbit IgG
Sera from anti-FSH-serum-exposed animals were treated overnight with protein A-agarose with a binding capacity of >=19 mg IgG/ml to remove any trace of the antibody and were used for FSH RIA using [125I]-rat FSH, rat FSH standards, and antirat FSH serum (NIH, Ref. 25).

Whether the antibody entered fetal blood was evaluated by injecting 200 µl anti-FSH serum into pregnant females, on 12DG, and the presence of rabbit IgG in the serum of 1-day-old hamsters was detected by Western immunoblotting (21). The stability of FSH-antiserum in the plasma of postnatal hamsters was evaluated by immunodetection of rabbit IgG in the sera of 8-day-old pups that received the antiserum either on 12DG or D1pn.

Determination of cAMP
cAMP was determined by using an RIA kit (Biomedical Research Instruments, Inc., Stoughton, MA) with a sensitivity of 0.05 pmol cAMP after acetylation. The data were presented as pmol cAMP per ml medium per 24 h.

Data analysis
Morphometric evaluation of folliculogenesis was done on at least 3 ovaries, which were collected from 3 different pups born to different mothers. Moreover, 250 or more oocytes from each ovary were counted to determine the percentage of follicles at each size class. Follicles were classified (26) as follows: stage 0, primordial follicles with 1 or more flattened parenchymal cells; stage 1, primary follicles with unlaminar granulosa cells, of which the majority were cuboidal; stage 2, secondary follicles with 2 layers of granulosa cells; stage 3, secondary follicles with 3 layers of granulosa cells; and stage 4, secondary follicles with 4 layers of granulosa cells. All data were analyzed by 2-way ANOVA and Scheffé’s test with 5% level of significance.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The polyclonal FSH antiserum detected a 40-kDa and a 29-kDa protein in ovine FSH preparation (Fig. 1Go), under a nonreducing condition, and cross-reacted with an approximately 23-kDa protein in ovine FSH preparation and in hamster pituitary lysate under a reducing condition (Fig. 2Go]) The electrophoretic pattern of FSH corresponded well with that provided by the NIH. Moreover, [125I]-ovine FSH binding to the antiserum was inhibited by proestrous hamster serum but not by the serum from long-term hypophysectomized hamsters or LH (Fig. 3Go). The antiserum also completely blocked antral follicle development in adult cyclic hamsters when administered before the second FSH peak (Fig. 4Go, A and B).



View larger version (99K):
[in this window]
[in a new window]
 
Figure 1. Western blot-chemiluminescence verification of the specificity of the anti-FSH-antibody. The specificity of the antibody was tested using 1 µg each of o-FSH-20, o-LH-25, o-Prl, and eCG under nonreducing conditions. The antibody cross-reacted only with FSH (40 kDa). The 29-kDa protein might represent a nonglycosylated form. Interestingly, the antibody did not even detect any {alpha}-subunit of LH.

 


View larger version (55K):
[in this window]
[in a new window]
 
Figure 2. Chemiluminescence analysis of the cross-reactivity of the FSH antiserum with ovine FSH and hamster pituitary lysate under reducing conditions. The antiserum detected a 23-kDa protein in the hamster pituitary lysate corresponding to reduced-ovine FSH subunits. Lanes 1 and 2, 0.25 and 0.5 µg ovine FSH-20, respectively; lane 3, pituitary lysate of proestrous hamsters.

 


View larger version (15K):
[in this window]
[in a new window]
 
Figure 3. Displacement of [125I]-ovine FSH binding to the FSH antiserum by proestrous hamster serum. The binding of [125I]-ovine FSH to the antiserum was challenged with increasing dosages of ovine-FSH, LH, and proestrous hamster serum after the preovulatory gonadotropin surge (D4: 1600 h) or serum from 10-day hypophysectomized female hamsters. Note that proestrous hamster serum competed with [125I]-FSH for the antiserum binding; however, LH and hypophysectomized hamster serum were without effect, indicating that FSH antiserum cross-reacts with hamster FSH. Hx, Hypophysectomy.

 


View larger version (158K):
[in this window]
[in a new window]
 
Figure 4. Photomicrographs of hamster ovaries at estrous (D1: 0900 h) after an sc injection of (A) preimmune rabbit serum or (B) anti-FSH-serum at proestrous (D4: 1600 h) of the previous estrous cycle. The occurrence of normal cyclicity and ovulation in serum-treated animals was evident by the presence of distinct corpora lutea (CL), nonovulated antral follicles (UF), and preantral follicles at stages 4 (S4), 5 (S5), and 6 (S6); however, no antral follicle or CL was present in the antibody-treated hamsters. PGs, Pyknotic granulosa cells; APF, atretic preantral follicle; aS5 and aS6, atretic S5 and S6, respectively; magnification, x50.

 
Antiserum inhibition of primordial follicle formation
That FSH-antiserum entered the fetal circulation was evident by the presence of rabbit IgG in15-day-old fetal hamster serum (Fig. 5Go); however, only a trace amount of rabbit IgG was present by D5pn when the antiserum was injected on 12DG (data not shown). The antiserum did not interfere with the gestation period, delivery time, placental weight, litter size, or litter weight. Moreover, the pups showed normal phenotype, milk intake, and postpartum weight gain, indicating that antiserum did not induce any adverse change in the phenotype that could be construed as a potential cause of retarded ovary development. No significant difference in the ovarian weight was noted between the control and antiserum-exposed pups by day D8pn (data not shown).



View larger version (64K):
[in this window]
[in a new window]
 
Figure 5. Chemiluminescence detection of rabbit IgG in 1-day-old hamster serum after an sc injection of FSH antiserum to pregnant females on 12DG. The presence of rabbit IgG in the hamster serum indicates that a considerable amount of FSH-antiserum enters the fetal circulation when injected into the mother. The blot was probed with a goat-antirabbit-IgG, which was preabsorbed with rat, mouse, hamster, bovine, and human IgG to further increase the specificity. Further, no signal was obtained when untreated hamster serum was probed with the antibody (lane 3). Lane 1, 2 µl serum from 1-day-old hamsters exposed to FSH-antiserum in utero; lane 2, 0.1 µl anti-FSH serum (rabbit serum); lane 3, 5 µl serum from untreated 1-day-old hamsters.

 
Eight-day-old ovaries from pups exposed to preimmune serum or saline on 12DG contained 24.8% primordial and 1.2% early primary follicles (Figs. 6AGo and 7Go), which was similar to untreated controls. However, antiserum exposure on 12DG dramatically reduced the proportion of primordial follicles to 2.4% and completely blocked primary follicle formation (Figs. 6BGo and 7Go). No further reduction in the proportion of primordial follicles was noted when the antiserum was injected on 10DG (data not shown). A gradual increase in primordial follicle formation was noted when the antiserum treatment was delayed to 13DG or 14DG (Fig. 7Go), but the values were still significantly lower than controls. No further improvement was noted when the antiserum was injected on D1pn. However, a small percentage of primary follicles developed (Fig. 7Go), suggesting that FSH-dependent morphogenesis of primordial follicles continues after birth, but the onset of FSH signaling may occur around 12DG.



View larger version (121K):
[in this window]
[in a new window]
 
Figure 6. Photomicrographs of 8-day-old hamster ovaries exposed to preimmune serum on 12DG (A), FSH-antiserum on 12DG (B), or FSH-antiserum on D12G and eCG on d1pn (C). A, The presence of primordial (S0) and primary (S1) follicles with distinct granulosa cells (Gc) reflects normal ovarian development. The majority of the oocytes (O) are in the dictyate stage. B, No distinct follicle formation is evident. Clusters of O in the Pachytene stage and cords of somatic cells (SC) indicate an arrest in primordial follicle formation. C, The resumption of S0 and S1 follicle formation with distinct Gc is evident after eCG administration on d1pn. A transitional S1 follicle (tS1) is also visible. Magnification, x400.

 


View larger version (16K):
[in this window]
[in a new window]
 
Figure 7. Follicular development in 8-day-old hamsters exposed to saline or the anti-FSH-serum during 12DG–14DG or day 1 of age. Note a dramatic reduction in primordial follicle and complete absence of primary follicle formation after FSH-inactivation. Delaying the antibody treatment allowed initial FSH action; and consequently, more primordial follicles developed; however, inactivation of FSH action, even after birth, significantly attenuated primordial follicle formation. The proportion of follicles in an ovary was expressed as percentage of oocytes because 8-day-old ovary contains primarily oocytes and a small proportion of developing primordial and primary follicles. Values with the same letters are significantly (P < 0.05) different from each other.

 
Serum levels of FSH were 11 ± 1 ng/ml in 8-day-old control female hamsters (Fig. 8Go), thus corroborating previous findings (5, 9). FSH levels were significantly (P < 0.05) low in 8-day-old hamsters exposed to the antiserum on 12DG; however, no FSH was detected when the antiserum was injected on D1pn (Fig. 8Go). FSH levels reached normal values (9 ±1 ng/ml) by D12pn after the antiserum exposure on 12DG, indicating a gradual reversal of the availability of endogenous FSH (hence, its action). Conversely, rabbit IgG was detectable in pups receiving the antiserum postnatally.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 8. Serum levels of FSH in 8-day- and 12-day-old hamsters exposed to the FSH-antiserum either on 12DG or d1pn. Control pups were exposed to preimmune serum. Values with the same letters are significantly (P < 0.05) different from each other.

 
In vitro production of cAMP by fetal hamster ovaries
Fetal hamster ovaries were capable of producing baseline levels of cAMP in vitro in the presence of MIX (Fig. 9Go). cAMP production increased more than 2-fold (P < 0.05) in response to FSH and more than 4-fold (P < 0.05) in response to forskolin (fig. 9Go).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 9. In vitro production of cAMP by 13-day-old fetal hamster ovaries. The ovaries were incubated with 0.5 mM methylisobutylxanthine, for 24 h, in the presence or absence of FSH or forskolin. A significant increase in cAMP production was noted in response to FSH or forskolin. Values with the same letter are significantly different from each other.

 
Reversal of the antiserum inhibition of primordial folliculogenesis by eCG or endogenous FSH
Administration of eCG, on D1pn, to pups exposed to antiserum on 12DG not only reversed the formation of primordial follicles to nearly control levels but also induced a small proportion of primary follicles (Figs. 6CGo and 10Go). The efficacy of eCG, however, declined significantly as the treatment was delayed by 4 or 6 days (Fig. 10Go), suggesting that primordial folliculogenesis is a relatively long FSH-dependent process.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 10. eCG (20 IU) reversal of the antiserum inhibition of follicle development in 8-day-old hamsters that were exposed to the antiserum on 12DG. Note that a single dose of eCG on D1pn significantly (P < 0.0001) reversed primordial follicle development by D8pn. Reduced induction of primordial follicle formation was noted when eCG treatment was delayed. Values with the same letters are significantly (P < 0.05) different from each other.

 
The presence of increasing amounts of FSH by D8pn and D12pn in pups exposed to the antiserum on 12DG correlated with increased development of primordial and primary follicles by D12pn (Fig. 11Go). In fact, the rate of primordial-to-primary follicle transition seemed to have accelerated, because there was no difference in the percentage of primary follicles between the control and antiserum-exposed pups despite a significantly lower percentage of primordial follicle development (Fig. 11Go). However, the percentage of stages 2 and 3 follicles (2 and 3 layers of granulosa cells, respectively) was significantly lower than in controls, and stage 4 follicles were completely absent (Fig. 11Go). This indicated that antiserum did not affect FSH receptors, given that eCG was able to function. Therefore, when clearance and degradation adequately reduced the serum antibody titer around D8pn (only a trace amount of rabbit IgG was present by D5pn), functional FSH levels began to increase, resulting in a compensatory induction of primordial follicles by D12pn and the formation of primary follicles. The delay in folliculogenesis beyond the primordial stage was more pronounced when the antiserum was administered on 13DG (Fig. 11Go).



View larger version (24K):
[in this window]
[in a new window]
 
Figure 11. Endogenous FSH reversal of the antiserum effect in 12-day-old hamsters exposed to the antiserum on 12DG or 13DG. Stages 2–4 were secondary follicles with 2–4 layers of granulosa cells, respectively. Values with the same letters are significantly (P < 0.05) different from each other.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
These results provide the first direct evidence that FSH is essential for somatic cell differentiation into early granulosa cells during the onset of primordial follicle development, at least in the hamster. The results also indicate that the initiation of critical FSH-mediated changes may occur between a window of 10DG and 12DG, but the process of somatic cell differentiation into granulosa cells continues during early postnatal life of the hamster. Moreover, inactivating FSH during the critical period delays the onset of primordial follicle formation (hence, subsequent folliculogenesis). FSH regulation of granulosa cell function requires the presence of functional FSH receptor and FSH ligand (27). Consistently detectable amounts of FSH are present in neonatal mice (28) and hamsters (5, 9). Moreover, FSH receptor messenger RNA (mRNA) corresponding to exons 1–10 and functional FSH receptors first appear at 5 days of age in the rat (29) and mouse (30). In contrast, a complementary DNA corresponding to full-length FSH receptor mRNA has been detected in the hamster fetus as early as 13DG (S. K. Roy, unpublished). That FSH mRNA is translated into functional FSH receptor protein in the fetal hamster ovary is evident by the production of cAMP in response to FSH in vitro. Moreover, ovarian response to forskolin also suggests that active adenylate cyclase has developed in ovarian somatic cells as early as 13 days of fetal life. Sokka and Huhtaniemi (22) have shown that neonatal rat ovaries can produce significantly more cAMP in response to 30 µg/ml human FSH than untreated controls as early as 4 days of postnatal life, but 17-day-old fetal ovary can respond to cholera toxin in terms of cAMP production. The difference in ovarian response to FSH between rats and hamster can be attributed to species difference. Nevertheless, these lines of evidence suggest that FSH modulation of follicular development occurs at early perinatal period.

Lack of FSH (8) by an inactivating mutation of either FSH-ß-subunit gene (10) or FSH-receptor gene (11) blocks preantral-to-antral follicle transition in homozygous mice, and genetic inactivation of growth differentiation factor-9 results in follicular arrest beyond the late primary stage (31). Because none of these studies has quantified primordial or primary follicle development, the results do not fully address the importance of FSH in primordial follicle development. It is likely that silencing the FSH gene in the mouse may activate other FSH-mediated compensatory mechanism(s), which induce follicular morphogenesis. In fact, overexpression of cyclin D2, a granulosa cell-specific mitotic cyclin (32), has been reported in FSH receptor knockout mice (11). Nevertheless, women with inactivating mutation in the extracellular domain of the FSH receptor have streak gonads (12, 13, 14) with few follicles. Although primordial follicles have been identified in ovaries with inactivating FSH-receptor mutation, it is unclear whether their number matches normal ovaries. Aittomaki et al. (12) have further documented that the mutation responsible for the development of hypoplastic ovaries in women occurs at the extracellular domain of the receptor and leads to reduced hormone binding and cAMP production capacity without affecting the affinity (12). These lines of evidence clearly indicate that a low, but residual, FSH-receptor activity may persist in the ovaries of women with FSH-receptor mutation, which can provide adequate signal for primordial follicle development. The development of a few primordial follicles in 8-day-old hamsters, after gestational exposure to the FSH-antiserum, confirms that low FSH activity may be adequate for the initiation of primordial follicle formation, but a prolonged FSH action is needed for the development of a full cohort of primordial follicles.

The inhibition of primordial follicle formation by the anti-FSH serum given during the critical window of FSH action on the fetal ovary, and its reversal by eCG, suggests that perinatal FSH plays an important role in the onset of somatic cell differentiation into granulosa cells, which is essential for the development of the very first cohort of primordial follicles. Moreover, FSH action seems to begin long before primordial follicles appear, i.e. by D7pn–D8pn of postnatal life. This notion is supported by the development of approximately 2.4% primordial follicles in pups exposed to the antiserum on 12DG. It is likely that only a few somatic cells are capable of processing the FSH signal by 12DG; and once committed, they differentiate into granulosa cells to form primordial follicles despite a subsequent block in FSH action. This is further evident by the progressive increase in primordial follicle development when antiserum treatment is delayed.

The failure to develop a full cohort of primordial follicles by D8pn, even when the antiserum treatment was delayed until D1pn, suggests that sustained FSH signaling is essential until all presumptive granulosa cells are differentiated and become associated with the oocyte to constitute the finite pool of primordial follicles. Interruption of FSH action, at anytime during this period, blocks further cell differentiation while cells that have already received FSH stimulus undergo differentiation, resulting in a final low number of primordial follicles. The presence of serum FSH in 8-day-old hamsters exposed to the antiserum on 12DG correlates with the decline in serum antiserum concentration and suggests that antiserum-induced inactivation of FSH is a reversible process. The temporal eCG action in reversing the antiserum inhibition supports this contention. Moreover, eCG reversal also indicates that the antiserum inhibition is specifically caused by inactivation of endogenous FSH and not a nonspecific antibody-mediated toxicity. This is further evident from the failure of the preimmune rabbit serum to block primordial follicle formation. Because LH-receptors do not appear in the hamster ovary before 15 days of age (33), eCG effect cannot be attributed to any inherent LH-like activity.

It seems that FSH-mediated differentiation of somatic cells into granulosa cells is a slow process, spanning through several days of the perinatal period (i.e. late prenatal through early postnatal) and can be halted at any time during this period without any permanent adverse consequence. Therefore, no differentiation induction may occur when FSH action is blocked on 10DG but will resume when FSH is available; and consequently, some primordial follicles will be formed by D8pn. On the other hand, if the initiation of FSH-mediated signaling occurs by 12DG, as evident in the present study, some cells will differentiate before the antibody, given on 12DG, completely neutralizes serum FSH and will form some primordial follicles by D8pn. This mechanism may explain why the development of primordial follicles cannot be blocked completely, even when the antiserum is injected before 12DG. The degree of initial differentiation (hence, the percentage of primordial follicles developed) by D8pn will depend on the timing of initiation of FSH inactivation.

A rapid induction of primordial follicles within 4 days after D8pn in gestationally antiserum-exposed hamsters suggests the possibility that 1) FSH availability increases after D8pn; and 2) somatic cell responsiveness to FSH heightens because of the increased presence of FSH receptors. Serum FSH levels in postnatal hamsters start to increase after D9pn (5, 9), and serum FSH levels are closer to the untreated values by D12pn in hamsters exposed to the antiserum on 12DG. If the antiserum inactivates FSH, a possible reduction in FSH-induced receptor down-regulation is likely, which may subsequently accelerate the process of differentiation. Because the presence of functional FSH receptors is a prerequisite for FSH action, factors inducing FSH receptors must work in conjunction with FSH for granulosa cell differentiation. Mayerhofer et al. (6) have suggested that cAMP inducers, such as vasoactive intestinal peptide, may be responsible for FSH receptor induction in neonatal rat ovary. Whether such a mechanism exists in the hamster needs further evaluation; however, the production of cAMP in response to FSH in vitro has been demonstrated in the present study.


    Acknowledgments
 
We thank the National Pituitary Program and Dr. A. F. Parlow for generously providing FSH and the FSH RIA kit. We are grateful to Dr. Gilbert S. Greenwald, University of Kansas Medical Center, for his meticulous help in the preparation of the manuscript.


    Footnotes
 
1 This work was supported by grants from National Institute of Child Health and Human Development (HD-28165) and Olson Foundation of Omaha. Back

Received May 15, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Greenwald GS, Roy SK 1994 Follicular selection. In: Knobil E, Neill JD (eds) The Physiology of Reproduction. Raven Press, New York, pp 629–724
  2. Simoni M, Gromoll J, Nieschlag E 1997 The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:739–773[Abstract/Free Full Text]
  3. Richards JS1994 Hormonal control of gene expression in the ovary. Endocr Rev 15:404–417
  4. Roy SK 1994 Regulation of ovarian follicular development: a review of microscopic studies. Microsc Res Tech 27:83–96[CrossRef][Medline]
  5. Roy SK, Hughes J 1994 Ontogeny of granulosa cells in the ovary: lineage specific expression of transforming growth factor-ß2 and transforming growth factor-ß1. Biol Reprod 51:821–830[Abstract]
  6. Mayerhofer A, Disney GA, Costa ME, Owed SR 1997 A role for neurotransmitters in early follicular development: induction of functional follicle-stimulating hormone receptors in newly formed follicles of the rat ovary. Endocrinology 138:3320–3329[Abstract/Free Full Text]
  7. Uilenbroek JTHJ, Arendsen DWE, Welschen R 1976 Studies on the significance of the high levels of follicle-stimulating hormone for follicular development in immature rats. Ann Biol Anim Biochem Biophys 16:297–305
  8. Halpin DMG, Jones A, Fink G, Charlton HM 1986 Postnatal ovarian follicle development in hypogonadal (hpg) and normal mice and associated changes in the hypothalamic pituitary axis. J Reprod Fertil 77:287–296[Abstract/Free Full Text]
  9. Vomachka AJ, Greenwald GS 1979 The development of gonadotropin and steroid hormone patterns in male and female from birth to puberty. Endocrinology 105:960–966[Abstract/Free Full Text]
  10. Kumar TR, Wang Y, Lu N, Matzuk MM 1998 Genetic rescue of follicle-stimulating hormone ß-deficient mice. Nat Genet 15:201–204
  11. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, Sassone-Corsi M 1998 Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 95:13612–13617[Abstract/Free Full Text]
  12. Aittomaki K, Lucena JLD, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Levaslaiho H, Engel AR, Nieschlag E, Huhtaniemi L, Chapelle ADL 1995 Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82:959–968[CrossRef][Medline]
  13. Aittomaki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O, Chapelle ADL 1996 Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 81:3722–3726[Abstract]
  14. Tapanainen JS, Vaskivuo T, Aittomaki K, Huhtaniemi IT 1998 Inactivating FSH receptor mutations and gonadal dysfunction. Mol Cell Endocrinol 145:129–135[CrossRef][Medline]
  15. Roy SK, Greenwald GS 1986a Quantitative analysis of in vitro incorporation of [3H]thymidine into hamster follicles during the estrous cycle. J Reprod Fertil 77:143–152
  16. Roy SK, Greenwald GS 1986b Effects of FSH, and LH on incorporation of [3H]thymidine into follicular DNA. J Reprod Fertil 78:201–209
  17. Roy SK, Greenwald GS 1989 Hormonal requirements for the growth and differentiation of hamster preantral follicles in long-term culture. J Reprod Fertil 87:103–114[Abstract/Free Full Text]
  18. Roy SK, Harris SG 1994 Antisense EGF oligonucleotide inhibits follicle-stimulating hormone-induced in vitro DNA and progesterone synthesis in hamster preantral follicles. Mol Endocrinol 8:1175–1181[Abstract/Free Full Text]
  19. Weakley BS 1967 Light and electron microscopy of developing germ cells and follicle cells in the ovary of the golden hamster: twenty-four hours before birth to eight days postpartum. J Anat 101:435–459[Medline]
  20. Roy SK, Greenwald GS 1990 Immunohistochemical localization of epidermal growth factor-like activity in the hamster ovary with a polyclonal antibody. Endocrinology 126:1309–1317[Abstract/Free Full Text]
  21. Roy SK, Kole AR 1995 Transforming growth factor-ß receptor type II (TßRII) expression in the hamster ovary: cellular site(s), biochemical properties and hormonal regulation. Endocrinology 136:4610–4620[Abstract]
  22. Sokka T, Huhtaniemi I 1990 Ontogeny of gonadotropin receptors and gonadotropin-stimulated cyclic AMP production in the neonatal rat ovary. J Endocrinol 127:297–303[Abstract/Free Full Text]
  23. Yu N, Roy SK 1999 Development of primordial and prenatal follicles from undifferentiated somatic cells and oocytes in the hamster prenatal ovary in vitro: effect of insulin. Biol Reprod 61:689–712
  24. Siegel HI, Bast JD, Greenwald GS 1976 The effects of phenobarbital and gonadal steroids on periovulatory serum levels of luteinizing hormone and follicle-stimulating hormone in the hamster. Endocrinology 98:48–55[Abstract/Free Full Text]
  25. Greenwald GS 1974 Quantitative aspects of follicular development in the untreated and PMS-treated cyclic hamster. Anat Rec 178:139–143[CrossRef][Medline]
  26. Roy SK, Greenwald GS 1985 An enzymatic method for dissociation of intact follicles from the hamster ovary: histological and quantitative aspects. Biol Reprod 32:203–215[Abstract]
  27. Tapanainen JS, Vaskivuo T, Aittomaki K, Huhtaniemi IT 1998 Inactivating FSH receptor mutations and gonadal dysfunction. Mol Cell Endocrinol 145:129–135
  28. Stiff ME, Bronson FH, Stetson MH 1974 Plasma gonadotropins in prenatal and prepubertal female mice: disorganization of pubertal cycles in the absence of a male. Endocrinology 94:492–496[Abstract/Free Full Text]
  29. Sokka TA, Hamalainen TM, Huhtaniemi IT 1992 Functional LH receptor appears in the neonatal rat ovary after changes in the alternate splicing pattern of the LH receptor mRNA. J Physiol Pharmacol 43: 21–31
  30. O’Shaughnessy PJ, Marsh P, Dudley K 1994 Follicle-stimulating hormone receptor mRNA in the mouse ovary during postnatal development in the normal mouse and in the adult hypogonadal (hpg) mouse: structure of alternate transcripts. Mol Cell Endocrinol 101:197–201[CrossRef][Medline]
  31. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM 1999 Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 13:1018–1034[Abstract/Free Full Text]
  32. Robker RL, Richards JS 1998 Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27kip1. Mol Endocrinol 12:924–940[Abstract/Free Full Text]
  33. Shaha C, Greenwald GS 1983 Development of steroidogenic activity in the ovary of the prepubertal hamster. Biol Reprod 28:1231–1242[CrossRef][Medline]



This article has been cited by other articles:


Home page
Endocr. Rev.Home page
D. Adhikari and K. Liu
Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles
Endocr. Rev., August 1, 2009; 30(5): 438 - 464.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Wang and S. K. Roy
Expression of Bone Morphogenetic Protein Receptor (BMPR) during Perinatal Ovary Development and Primordial Follicle Formation in the Hamster: Possible Regulation by FSH
Endocrinology, April 1, 2009; 150(4): 1886 - 1896.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
E. A McLaughlin and S. C McIver
Awakening the oocyte: controlling primordial follicle development
Reproduction, January 1, 2009; 137(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J.L.H. Ireland, D. Scheetz, F. Jimenez-Krassel, A.P.N. Themmen, F. Ward, P. Lonergan, G.W. Smith, G.I. Perez, A.C.O. Evans, and J.J. Ireland
Antral Follicle Count Reliably Predicts Number of Morphologically Healthy Oocytes and Follicles in Ovaries of Young Adult Cattle
Biol Reprod, December 1, 2008; 79(6): 1219 - 1225.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Wang, E. R. Prossnitz, and S. K. Roy
G Protein-Coupled Receptor 30 Expression Is Required for Estrogen Stimulation of Primordial Follicle Formation in the Hamster Ovary
Endocrinology, September 1, 2008; 149(9): 4452 - 4461.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y. Morimoto, Y. Oku, M. Sonoda, A. Haruki, K. Ito, S. Hashimoto, and A. Fukuda
High oxygen atmosphere improves human follicle development in organ cultures of ovarian cortical tissues in vitro
Hum. Reprod., December 1, 2007; 22(12): 3170 - 3177.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Wang and S. K. Roy
Development of Primordial Follicles in the Hamster: Role of Estradiol-17{beta}
Endocrinology, April 1, 2007; 148(4): 1707 - 1716.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Wang and S. K. Roy
Expression of Growth Differentiation Factor 9 in the Oocytes Is Essential for the Development of Primordial Follicles in the Hamster Ovary
Endocrinology, April 1, 2006; 147(4): 1725 - 1734.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C M Allan, Y Wang, M Jimenez, B Marshan, J Spaliviero, P Illingworth, and D J Handelsman
Follicle-stimulating hormone increases primordial follicle reserve in mature female hypogonadal mice.
J. Endocrinol., March 1, 2006; 188(3): 549 - 557.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Steckler, J. Wang, F. F. Bartol, S. K. Roy, and V. Padmanabhan
Fetal Programming: Prenatal Testosterone Treatment Causes Intrauterine Growth Retardation, Reduces Ovarian Reserve and Increases Ovarian Follicular Recruitment
Endocrinology, July 1, 2005; 146(7): 3185 - 3193.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Yang, J. Wang, Y. Shen, and S. K. Roy
Developmental Expression of Estrogen Receptor (ER) {alpha} and ER{beta} in the Hamster Ovary: Regulation by Follicle-Stimulating Hormone
Endocrinology, December 1, 2004; 145(12): 5757 - 5766.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y.-M. Zhang and S. K. Roy
Downregulation of Follicle-Stimulating Hormone (FSH)-Receptor Messenger RNA Levels in the Hamster Ovary: Effect of the Endogenous and Exogenous FSH
Biol Reprod, June 1, 2004; 70(6): 1580 - 1588.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Wang and S. K. Roy
Growth Differentiation Factor-9 and Stem Cell Factor Promote Primordial Follicle Formation in the Hamster: Modulation by Follicle-Stimulating Hormone
Biol Reprod, March 1, 2004; 70(3): 577 - 585.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Balla, N. Danilovich, Y. Yang, and M. R. Sairam
Dynamics of Ovarian Development in the FORKO Immature Mouse: Structural and Functional Implications for Ovarian Reserve
Biol Reprod, October 1, 2003; 69(4): 1281 - 1293.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roy, S. K.
Right arrow Articles by Albee, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, S. K.
Right arrow Articles by Albee, L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals